Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Neurology Devices Market     Nerve Repair & Regeneration Market     Global Neurostimulation/Neuromodulation Market     Global Internal Neurostimulation Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019

  • Report Code: IN 1000
  • Publish Date: Mar 2015
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% during the forecast period. Rise in the incidences and prevalence of neurological diseases, rapid growth in aging population, development of advanced neurostimulation/neuromodulation technologies, and increasing awareness are some of the key factors that are fueling the growth of the neurostimulation/neuromodulation market in the region. However, lack of skilled professionals and unfavorable reimbursement scenario are some of the key challenges faced by the market players.

 

The emerging markets including China and India have become the key growth segments for the companies engaged in the development and marketing of the internal neurostimulation/neuromodulation implants. Rising incidences of neurological disorders and government initiatives to increasing awareness by education campaigns are the key factors propelling the demand of neuromodulation devices and technologies in the emerging markets.

 

Medtronic, Inc. (U.S.) held the leading position in the Asia-Pacific internal neurostimulation/neuromodulation market. In recent years, the company has adopted expansion of its R&D capabilities, new product launches, and geographical expansion as its key business strategies to ensure its dominant position in this market. St. Jude Medical Inc. (U.S.) and Boston Scientific Inc. (U.S.) are some other key players competing in the Asia-Pacific internal neurostimulation/neuromodulation market.

 

Scope of the Report

This research report categorizes the Asia-Pacific internal neurostimulation/neuromodulation market into the following segments and sub-segments:

 

 Asia-Pacific Internal Neurostimulation/Neuromodulation Market, by Modality

           * Spinal Cord Stimulator

           * Deep Brain Stimulator

           * Sacral Nerve Stimulator

           * Vagus Nerve Stimulator

           * Gastric Neurostimulator

 

Asia-Pacific Internal Neurostimulation/Neuromodulation Market, by Application

        * Spinal Cord Stimulator

          Chronic Pain

          Failed back surgery syndrome

          Ischemic Pain

          Others

        * Deep Brain Stimulator

          Parkinson's Disease

          Tremor

          Depression

          Others (Chronic Pain, Dystonia, Tourette's Syndrome, Alzheimer's)

        * Sacral Nerve Stimulator

          Urinary Incontinence

          Fecal Incontinence

        * Vagus Nerve Stimulator

          Epilepsy

          Others

        * Gastric Neurostimulator

          Gastropareisis

 

Asia-Pacific Internal Neurostimulation/Neuromodulation Market, by Geography

        * Asia-Pacific

          China

     Japan

     India

     Republic of Korea

        Rest of Asia-Pacific

 




Table of Contents

 

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

 

2 Research Methodology (Page No. - 15)
    2.1 Integrated Ecosystem of the Internal Neurostimulation/Neuromodulation Market
    2.2 Arriving at the Neuromostimulation/Neuromodulation Market Size
          2.2.1 Market Share
          2.2.2 Top-Down Approach
          2.2.3 Bottom-Up Approach
          2.2.4 Macro Indicator-Based Approach

 

3 Asia-Pacific Internal Neuromodulation/Neurostimulation Market: Macro Indicators,  By Geography, 2014 ($ Bn) (Page No. - 21)
    3.1 Assumptions

 

4 Executive Summary (Page No. - 23)

 

5 Market Overview (Page No. - 25)
    5.1 Introduction
    5.2 Internal Neurostimulation/Neuromodulation Market: Comparison With the Parent Market
    5.3 Market Drivers And Inhibitors

 

6 Internal Neurostimulation/Neuromodulation Market, By Modality (Page No. - 32)
    6.1 Introduction
    6.2 Spinal Cord Stimulation
    6.3 Deep Brain Stimulation
    6.4 Sacral Nerve Stimulation
    6.5 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
    6.6 Vagus Nerve Stimulaton
    6.7 Gastric Electrical Stimulation (GES)


 7 Internal Neurostimulation/Neuromodulation Market, By Application (Page No. - 46)
    7.1 Introduction
          7.1.1 Asia-Pacific Spinal Cord Stimulation (SCS) Market, By Application
          7.1.2 Asia-Pacific Deep Brain Stimulation (DBS) Market, By Application
          7.1.3 Sacral Nerve Stimulation (SNS) Market, By Application
          7.1.4 Vagus Nerve Stimulation (VNS) Market, By Application
          7.1.5 Gastric Electrical Stimulation (GES) Market, By Application

 

8 Internal Neurostimulation/Neuromodulation Market, By Geography (Page No. - 57)
    8.1 Introduction
          8.1.1 Japan Internal Neurostimulation Market, By Modality
          8.1.2 Spinal Cord Stimulation (SCS) Neurostimulation Market in Japan, By Application
          8.1.3 Deep Brain Stimulation (DBS) Neurostimulation Market in Japan, By Application
          8.1.4 China Internal Neurostimulation Market, By Modality
          8.1.5 Spinal Cord Stimulation (SCS) Neurostimulation Market in China, By Application
          8.1.6 Deep Brain Stimulation (SCS) Neurostimulation Market in China, By Application
          8.1.7 Deep Brain Stimulation (SCS) Neurostimulation Market in China, By Application
          8.1.8 India Internal Neurostimulation Market, By Modality
          8.1.9 Spinal Cord Stimulation (SCS) Neurostimulation Market in India, By Application
          8.1.10 Deep Brain Stimulation (SCS) Neurostimulation Market in India, By Application
          8.1.11 Republic of Korea Internal Neurostimulation Market, By Modality
          8.1.12 Deep Brain Stimulation (DBS) Neurostimulation Market in Republic of Korea, By Application
          8.1.13 Rest of Asia Internal Neurostimulation Market, By Modality
          8.1.14 Spinal Cord Stimulation (SCS) Neurostimulation Market in Rest of Asia, By Application
          8.1.15 Deep Brain Stimulation (DBS) Neurostimulation Market in Rest of Asia, By Application

 

9 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape (Page No. - 103)
    9.1 Internal Neurostimulation/Neuromodulation Market: By Company
    9.2 New Product Launch


 10 Internal Neurostimulation/ Neuromodulation Market, By Company (Page No. - 107)
    10.1 Boston Scientific Corporation (U.S.)
    10.2 Cerbomed Gmbh (Germany)
           10.2.1 Overview
           10.2.2 Key Financials
           10.2.3 Product And Service Offerings
           10.2.4 Related Developments
    10.3 Cyberonics, Inc. (U.S.)
           10.3.1 Overview
           10.3.2 Key Financials
           10.3.3 Product And Service Offerings
           10.3.4 Related Developments
    10.4 Depuy Synthes Companies (U.S.)
           10.4.1 Overview
           10.4.2 Key Financials
           10.4.3 Product And Service Offerings
           10.4.4 Related Developments
    10.5 Enteromedics, Inc. (U.S.)
           10.5.1 Overview
           10.5.2 Key Financials
           10.5.3 Product And Service Offerings
           10.5.4 Related Developments
    10.6 Medtronic, Inc. (U.S.)
           10.6.1 Overview
           10.6.2 Key Financials
           10.6.3 Product And Service Offerings
           10.6.4 Related Developments
    10.7 St. Jude Medical (U.S.)
           10.7.1 Overview
           10.7.2 Key Financials
           10.7.3 Product And Service Offerings
           10.7.4 Related Developments
    10.8 Synapse Biomedical, Inc. (U.S.)
           10.8.1 Overview
           10.8.2 Key Financials
           10.8.3 Product And Service Offerings
           10.8.4 Related Developments
    10.9 Uroplasty, Inc. (U.S.)
           10.9.1 Overview
           10.9.2 Key Financials
           10.9.3 Product And Service Offerings
           10.9.4 Related Developments

 

11 Appendix (Page No. - 126)
    11.1 Customization Options
           11.1.1 Product Analysis
           11.1.2 Epidemiology Data
           11.1.3 Surgeons/Physicians Perception Analysis
           11.1.4 Regulatory Framework
    11.2 Related Reports
    11.3 Introducing RT:Real-Time Market Intelligence
           11.3.1 Snapshots

 

List of Tables

 

Table 1 Asia-Pacific Internal Neurostimulation/Neuromodulation Market: Comparison  With Parent Market, 2013 – 2018 (USD MN)
Table 2 Internal Neuromodulation/Neurostimulation Market, By Geography, 2013 - 2019 (USD Thousand)
Table 3 Internal Neuromodulation/Neurostimulation Market in Asia-Pacific: Drivers And Inhibitors
Table 4 Internal Neurostimulation/Neuromodulation Market in Asia-Pacific, By Modality, 2013 - 2019 (USD Thousand)
Table 5 Spinal Cord Stimulation Market, By Geography,  2013–2019 (USD Thousand)
Table 6 Deep Brain Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Table 7 Vagus Nerve Stimulation Market, By Geography,  2013–2019 (USD Thousand)
Table 8 Gastric Electrical Stimulation Masks Market, By Geography,  2013–2019 (USD Thousand)
Table 9 Asia-Pacific Spinal Cord  Stimulation (SCS) Market, By Application, 2013 - 2019 (USD Thousand)
Table 10 Asia-Pacific Deep Brain  Stimulation (DBS) Market, By Application, 2013 - 2019 (USD Thousand)
Table 11 Asia-Pacific Sacral Nerve Stimulation (SNS) Market, By Application, 2013 - 2019 (USD Thousand)
Table 12 Asia-Pacific Vagus Nerve Stimulation (VNS) Market, By Application, 2013 - 2019 (USD Thousand)
Table 13 Asia-Pacific Gastric Electric Stimulation (GES) Market, By Application, 2013 - 2019 (USD Thousand)
Table 14 Internal Neurostimulation/Neuromodulation Market in Japan, By Modality, 2013 - 2019 (USD Thousand)
Table 15 Spinal Cord Stimulation (SCS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Table 16 Deep Brain Stimulation (DBS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Table 17 Sacral Nerve Stimulation (SNS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Table 18 Vagus Nerve Stimulation (VNS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Table 19 Gastric Electrical Stimulation (GES) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Table 20 Internal Neurostimulation/Neuromodulation Market in China, By Modality, 2013 - 2019 (USD Thousand)
Table 21 Spinal Cord Stimulation (SCS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Table 22 Deep Brain Stimulation (DBS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Table 23 Sacral Nerve Stimulation (SNS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Table 24 Vagus Nerve Stimulation (VNS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Table 25 Gastric Electrical Stimulation (GES) Market in China, By Application, 2013 - 2019 (USD Thousand)
Table 26 Internal Neurostimulation/Neuromodulation Market in India, By Modality, 2013 - 2019 (USD Thousand)
Table 27 Spinal Cord Stimulation (SCS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Table 28 Deep Brain Stimulation (DBS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Table 29 Sacral Nerve Stimulation (SNS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Table 30 Vagus Nerve Stimulation (VNS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Table 31 Gastric Electrical Stimulation (GES) Market in India, By Application, 2013 - 2019 (USD Thousand)
Table 32 Internal Neurostimulation/Neuromodulation Market in Republic of Korea, By Modality, 2013 - 2019 (USD Thousand)
Table 33 Spinal Cord Stimulation (SCS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Table 34 Deep Brain Stimulation (DBS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Table 35 Sacral Nerve Stimulation (SNS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Table 36 Vagus Nerve Stimulation (VNS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Table 37 Gastric Electrical Stimulation (GES) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Table 38 Internal Neurostimulation/Neuromodulation Market in Rest of Asia, By Modality, 2013 - 2019 (USD Thousand)
Table 39 Spinal Cord Stimulation (SCS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Table 40 Deep Brain Stimulation (DBS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Table 41 Sacral Nerve Stimulation (SNS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Table 42 Vagus Nerve Stimulation (VNS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Table 43 Gastric Electrical Stimulation (GES) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Table 44 Internal Neurostimulation/ Neuromodulation  Market: By Company
Table 45 Asia-Pacific Internal Neuromodulation Market: New Product Launch
Table 46 Regulatory ApprovalsAsia-Pacific Internal Neuromodulation Market: Regulatory Approvals 104
Table 47 Boston Scientific Corporation: Key Financials,
Table 48 Boston Scientific: Key Financials, By Geography, 2009 – 2012 (USD Million)
Table 49 Cyberonics, Inc.: Key Financials, 2009 - 2013 (USD Million)
Table 50 Johnson & Johnson, Inc. : Key Financials, By Segment, 2009 - 2013 (USD Million)
Table 1 Johnson & Johnson, Inc.: Key Financials, 2009 - 2013 (USD Million)
Table 2 Medtronic, Inc. : Key Financials, By Segment, 2009 - 2013 (USD Million)
Table 3 Medtronic, Inc. : Key Financials, 2009 - 2013 (USD Million)
Table 4 St. Jude Medical: Key Financials, By Segment, 2011 - 2013 (USD Million)
Table 5 St. Jude Medical: Key Financials, By Geography, 2008 - 2013 (USD Million)
Table 6 Uroplasty, Inc. : Key Financials, By Geography, 2011 - 2013 (USD Million)

 

List of Figures
 
Figure 1 Asia-Pacific Neurostimulation/Neuromodulation Market Segmentation & Coverage
Figure 2 Internal Neurostimulation/Neuromodulation Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Internal Neurostimulation/Neuromodulation Market in Asia-Pacific, By Country, 2013–2019 (USD MN)
Figure 5 Internal Neurostimulation/Neuromodulation Market in Asia-Pacific, By Modality, 2013–2019 (USD Thousand)
Figure 6 Spinal Cord Stimulation Market, By Geography,  2013–2019 (USD Thousand)
Figure 7 Deep Brain Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 8 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 9 Vagus Nerve Stimulation Market, By Geography, 2013–2019 (USD Thousand)
Figure 10 Gastric Electrical Stimulation Masks Market, By Geography,  2013–2019 (USD Thousand)
Figure 11 Internal Neurostimulation/Neuromodulation Market in Japan, By Modality, 2013–2019 (USD Thousand)
Figure 12 Spinal Cord Stimulation (SCS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Figure 13 Deep Brain Stimulation (DBS) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Figure 14 Sacral Nerve Stimulation (SNS) Market in Japan, By Application, 2013 - 2019 (USD MN)
Figure 15 Vagus Nerve Stimulation (VNS) Market in Japan, By Application, 2013 - 2019 (USD MN)
Figure 16 Gastric Electrical Stimulation (GES) Market in Japan, By Application, 2013 - 2019 (USD Thousand)
Figure 17 China Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 18 Internal Neurostimulation/Neuromodulation Market in China, By Modality, 2013–2019 (USD Thousand)
Figure 19 Spinal Cord Stimulation (SCS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Figure 20 Deep Brain Stimulation (DBS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Figure 21 Sacral Nerve Stimulation (SNS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Figure 22 Vagus Nerve Stimulation (VNS) Market in China, By Application, 2013 - 2019 (USD Thousand)
Figure 23 Gastric Electrical Stimulation (GES) Market in China, By Application, 2013 - 2019 (USD Thousand)
Figure 24 India Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 25 Internal Neurostimulation/Neuromodulation Market in India, By Modality, 2013–2019 (USD Thousand)
Figure 26 Spinal Cord Stimulation (SCS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Figure 27 Deep Brain Stimulation (DBS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Figure 28 Sacral Nerve Stimulation (SNS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Figure 29 Vagus Nerve Stimulation (VNS) Market in India, By Application, 2013 - 2019 (USD Thousand)
Figure 30 Gastric Electrical Stimulation (GES) Market in India, By Application, 2013 - 2019 (USD Thousand)
Figure 31 Republic of Korea Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 32 Internal Neurostimulation/Neuromodulation Market in Republic of Korea, By Modality, 2013–2019 (USD Thousand)
Figure 33 Spinal Cord Stimulation (SCS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Figure 34 Deep Brain Stimulation (DBS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Figure 35 Sacral Nerve Stimulation (SNS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Figure 36 Vagus Nerve Stimulation (VNS) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Figure 37 Gastric Electrical Stimulation (GES) Market in Republic of Korea, By Application, 2013 - 2019 (USD Thousand)
Figure 38 Rest of Asia Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 39 Internal Neurostimulation/Neuromodulation Market in Rest of Asia, By Modality, 2013–2019 (USD Thousand)
Figure 40 Spinal Cord Stimulation (SCS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Figure 41 Deep Brain Stimulation (DBS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Figure 42 Sacral Nerve Stimulation (SNS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Figure 43 Vagus Nerve Stimulation (VNS) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Figure 44 Gastric Electrical Stimulation (GES) Market in Rest of Asia, By Application, 2013 - 2019 (USD Thousand)
Figure 45 Boston Scientific Corporation Revenue Mix, 2013
Figure 46 Johnson & Johnson, Inc. Revenue Mix, 2013
Figure 47 Medtronic, Inc. Revenue Mix, 2013
Figure 48 St. Jude Medical. Revenue Mix, 2013

The Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into five main modalities, Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Gastric Neurostimulator. The Spinal Cord Stimulator market is estimated to account for the larger share of the Asia-Pacific internal neurostimulation/neuromodulation market in 2014. However, the Gastric Neurostimulator market is projected to register the higher CAGR in coming years, owing to various factors, such as increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which provides a significant growth opportunity for players in this segment.

 

The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain, and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others.

 

The Asia-Pacific internal neurostimulation/neuromodulation markets expected to reach a value of $573.3 Million by 2019 and is estimated to grow at a CAGR of 13.8% from 2014 to 2019.

 

Various factors, including rising incidence/prevalence of neurological diseases, rapid growth in aging population, public initiatives to increase awareness, technological developments, government investments and growing adoption of technologies are driving the growth of the Asia-Pacific internal neurostimulation/neuromodulation market. However, lack of skilled professionals is a key challenge faced by market players.

 

On the basis of geography, this market is classified into five regions, namely, (China, Japan, India, Republic of Korea, and the Rest of Asia-Pacific). In 2014, the Asia-Pacific internal gastroparesis market was dominated by Japan with a 53.0% market share. Various factors, such as technological advancements, increasing government funding in research and product development, and rising awareness are driving the growth of the neurostimulation/neuromodulation technologies market in Japan. However, the Indian market is estimated to register the highest CAGR between 2014 and 2019 owing to increasing aging population.

 

New product launches and product approvals are the key strategies adopted by the leading players to develop their position in the Asia-Pacific internal neurostimulation/neuromodulation market. Moreover, other strategies, including partnerships, agreements, collaborations, joint ventures, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and to expand their geographic presence.

 

Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) are the leading players in the Asia-Pacific internal neurostimulation/neuromodulation market.

Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Asian Neurostimulation/Neuromodulation devices Market Asian Neurostimulation/Neuromodulation devices Market
The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
European Neurostimulation/Neuromodulation Devices Market European Neurostimulation/Neuromodulation Devices Market
The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market.
May 2015
North America Internal Neuromodulation Devices Market North America Internal Neuromodulation Devices Market
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.
May 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539